- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 5 - Value-based Decisions in NSCLC
Dr Peskin discusses programs such as Choosing Wisely and how providers must be mindful of high value, cost-conscious, cost-aware care.
Dr Peskin discusses programs such as Choosing Wisely and how providers must be mindful of “high value, cost-conscious, cost-aware” care. This ensures that only appropriate treatments are administered to patients with cancer.
Dr Sugarbaker suggests to the fellow panelists that the majority of NSCLC patients are not candidates for surgery because they are diagnosed too late for a procedure. Early detection would save a lot of money.
“The issue of imaging and early detection certainly resonates with payers, including myself, and not only economic but ethical considerations,” says Dr Peskin. He adds that while people gravitate toward the terms “targeted” and “precision,” one must verify that those treatments are used by clinicians and oncologists judicially.
Managed Care Reflections: A Q&A With A. Mark Fendrick, MD, and Michael E. Chernew, PhD
December 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The December issue features a conversation with AJMC Co–Editors in Chief A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design and a professor at the University of Michigan in Ann Arbor; and Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy and the director of the Healthcare Markets and Regulation Lab at Harvard Medical School in Boston, Massachusetts.
Read More
